Business Context and Reporting Period
Company: Triton International Limited
Filing Type: Form 8-K (Current Report)
Date of Report: March 12, 2019
Event: The Company announced the pricing and expected consummation of a public offering of 8.50% Series A Cumulative Redeemable Perpetual Preference Shares.
Key Financial Metrics and Capital Structure
This filing details a capital raise event rather than operational financial performance. Key metrics related to the transaction include:
- Security Type: 8.50% Series A Cumulative Redeemable Perpetual Preference Shares.
- Shares Offered: 3,000,000 Series A Preference Shares.
- Liquidation Preference: $25.00 per share.
- Over-Allotment Option: Underwriters granted a 30-day option to purchase up to an additional 450,000 shares.
- Expected Closing Date: March 15, 2019.
Note: The filing text does not provide values for revenue, profit, cash flow, operating margins, existing debt levels, or liquidity ratios.
Material Changes
The primary material change is the amendment to the Company's capital structure through the adoption of a Certificate of Designations on March 12, 2019, establishing the terms for the new Series A Preference Shares. This represents a new class of perpetual debt-like equity with a fixed dividend rate of 8.50%.
Outlook, Risks, and Management Commentary
Management Action: The Board of Directors authorized the offering to raise capital. The Company filed a prospectus supplement and an Underwriting Agreement with major financial institutions including Wells Fargo, Merrill Lynch, Morgan Stanley, and RBC Capital Markets.
Contingencies: The consummation of the sale is subject to the terms and conditions of the Underwriting Agreement dated March 12, 2019.
Risks: The filing does not explicitly list new risk factors beyond the standard terms of the preference shares (e.g., redemption rights, cumulative dividends) which are detailed in the attached Certificate of Designations.
Investor Verification Checklist
- Verify the final closing date and total proceeds from the offering (including any exercise of the over-allotment option).
- Review the full text of the Certificate of Designations (Exhibit 4.1) for specific redemption dates, dividend payment schedules, and conversion rights.
- Confirm the use of proceeds as detailed in the accompanying Prospectus Supplement.
- Check subsequent filings for the actual issuance of the 3,000,000 base shares and any additional shares under the 30-day option.